Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae

Background: Carbapenems are the drug of choice for treatment of infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. Current evidence regarding piperacillin-tazobactam (PTZ) as an effective treatment alternative remains controversial. The purpose of this study was...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hosp Pharm
Auteurs principaux: Tullos, Jordan Brooke, Stoudenmire, Laura Leigh, Pouliot, Jonathon David
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2018
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961149/
https://ncbi.nlm.nih.gov/pubmed/31983766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578718817933
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires